2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
54
Neoplasms
38
Lung Neoplasms
24
Colorectal Neoplasms
24
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Hematologic Neoplasms
9
Anxiety Disorders
9
Urinary Bladder Neoplasms
8
Obesity
8
Melanoma
8
Lymphoma
8
Depression
8
Ovarian Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Sarcoma
5
Papillomavirus Infections
5
Pain
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Interventions
Sorafenib
222
lenvatinib
147
Bevacizumab
131
Nivolumab
86
atezolizumab
80
pembrolizumab
74
Radiosurgery
71
durvalumab
63
sintilimab
61
Oxaliplatin
60
Fluorouracil
56
Doxorubicin
47
tislelizumab
46
apatinib
44
Radiofrequency Ablation
44
Hepatectomy
43
Leucovorin
41
camrelizumab
40
Radiotherapy
40
tremelimumab
37
Magnetic Resonance Spectroscopy
36
regorafenib
34
Capecitabine
30
Immune Checkpoint Inhibitors
29
Folfox protocol
29
Cisplatin
28
Gemcitabine
26
Cyclophosphamide
26
cabozantinib
25
Ipilimumab
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Methods
×
Clear all
NCT07120750
2025-08-13
PRTRAS 001
Shenzhen Third People's Hospital
Not yet recruiting
332 enrolled